At $292.59, International Business Machines (NYSE:IBM | IBM Price Prediction) is a Buy, echoing Jim Cramer’s call on Mad Money after a viewer asked for a verdict on the stock. Cramer called IBM inexpensive, praised CEO Arvind Krishna’s execution, and told viewers to buy some now and add on any panic dips.
IBM sits at the intersection of enterprise software, hybrid cloud, and mainframe infrastructure, with 96% of its software portfolio classified as enabling infrastructure, not applications. Big Blue has methodically become an AI infrastructure supplier for global corporations, and Krishna has spent years reshaping the portfolio for this moment. The stock has rebounded from early-year lows but still trails the broader market, which is the setup Cramer is pointing at.
Why the Bulls See a Cheap AI Infrastructure Compounder
IBM’s Q1 2026 results strengthen the bull case. Non-GAAP EPS came in at $1.91 versus $1.81 expected, the fourth straight quarterly beat, on revenue of $15.917B, up 9.5% year over year. Software revenue rose 11.3% with Red Hat up 13% and Data up 19%, while IBM Z mainframe revenue surged 51% and infrastructure segment margin expanded from 8.6% to 15.8%.
Krishna is monetizing AI at the silicon layer. A fully populated mainframe can now run “about 450 billion inferences [operations] a day”, letting banks apply fraud models to every transaction instead of a 10% sample. The generative AI book of business finished 2025 above $12.5B inception-to-date. Meanwhile, management maintained guidance for more than 5% constant currency revenue growth and roughly $1 billion of incremental YoY free cash flow in 2026. At a forward P/E of 23, that is a growth business trading like a legacy one.
Why the Bears Say the Rerating Has Already Happened
IBM traded as low as $212.34 in the past year and now sits near $292.94 against a 52-week high of $332.46. Consulting, roughly a third of revenue, grew just 1% in constant currency, a soft spot bears argue will worsen as clients redirect budgets toward hyperscaler-native AI stacks.
Leverage is climbing. Total debt sits at $66.4 billion after the acquisition of data-streaming platform Confluent, while cash, restricted cash, and marketable securities fell to $11.8 billion from $14.5 billion. Free cash flow did not crack in Q1. It rose to $2.2 billion, up $0.3 billion year over year, even as IBM absorbed acquisition-related spending. The bear case is balance-sheet pressure, with cash down from year-end and debt elevated after another large software deal. Composite sentiment has slid 16.59 points over seven days, and Reddit discussion has cooled from bullish readings of 65 in late June to a bearish range of 36 to 42 in early July, with one r/stocks thread framing IBM as a “forgotten” tech name.
Why Patience Has a Real Case Too
The Wall Street consensus analyst target sits at $294.57, essentially where IBM stock already trades. Q2 results land soon. Polymarket assigns a 90% probability of an earnings beat but only a 48.5% probability of software revenue clearing $8.2B, leaving room for a mixed earnings report that stalls the stock.
Patient investors can watch three things: software acceleration toward the 10% plus full-year target, whether consulting inflects above 1% constant currency, and Confluent integration progress.
What the Numbers Say About the Setup
IBM trades at $292.72 against an average analyst target of $294.57, implied upside of roughly 1.6%, across 23 analysts. The ratings skew bullish: 3 Strong Buy, 12 Buy, 7 Hold, 0 Sell, and 1 Strong Sell.
Valuation is 25 trailing and 23 forward, with a 2.28% dividend yield resting on 31 consecutive years of increases. IBM is down 1.64% year to date and up 2.62% over one year, while the S&P 500 is up 10.71% year to date and 20.63% over one year.
Why the Bull Case Holds at This Price
Trading above $290, the bull case leans on three catalysts over the next 12 months. Q2 results later this month are the near-term trigger, with prediction markets pricing a 90% probability of a beat. Behind it sits a software segment that management expects to grow above 10% for the full year, and a mainframe cycle where Z17 hardware placement value ran more than $1 billion ahead of Z16’s first year. Together, those catalysts give IBM two ways to rerate: stronger earnings and a higher multiple.
Buying a business growing revenue 9.5% and free cash flow 13% at a forward multiple of 23 leaves margin for error that hyperscalers do not offer. Krishna is executing on a portfolio he built for this moment, telling analysts “this is a tailwind because of the model that we picked”. The thesis breaks if software growth stalls below 8%, consulting turns negative, or the Confluent integration slips.
Cramer’s framing captures it vividly: this is a high-quality operator being priced like a legacy laggard, and the market has not caught up.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks